Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,791 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Active site localization of methane oxidation on Pt nanocrystals.
Kim D, Chung M, Carnis J, Kim S, Yun K, Kang J, Cha W, Cherukara MJ, Maxey E, Harder R, Sasikumar K, K R S Sankaranarayanan S, Zozulya A, Sprung M, Riu D, Kim H. Kim D, et al. Among authors: chung m. Nat Commun. 2018 Aug 24;9(1):3422. doi: 10.1038/s41467-018-05464-2. Nat Commun. 2018. PMID: 30143615 Free PMC article.
Time-resolved in situ visualization of the structural response of zeolites during catalysis.
Kang J, Carnis J, Kim D, Chung M, Kim J, Yun K, An G, Cha W, Harder R, Song S, Sikorski M, Robert A, Thanh NH, Lee H, Choi YN, Huang X, Chu YS, Clark JN, Song MK, Yoon KB, Robinson IK, Kim H. Kang J, et al. Among authors: chung m. Nat Commun. 2020 Nov 19;11(1):5901. doi: 10.1038/s41467-020-19728-3. Nat Commun. 2020. PMID: 33214547 Free PMC article.
Study on the Korean adult cranial capacity.
Hwang YI, Lee KH, Choi BY, Lee KS, Lee HY, Sir WS, Kim HJ, Koh KS, Han SH, Chung MS, et al. Hwang YI, et al. Among authors: chung ms. J Korean Med Sci. 1995 Aug;10(4):239-42. doi: 10.3346/jkms.1995.10.4.239. J Korean Med Sci. 1995. PMID: 8593202 Free PMC article.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
5,791 results